Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.43USD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
108,091
52-wk High
$1.80
52-wk Low
$0.43

Latest Key Developments (Source: Significant Developments)

Acasti Pharma Files For Mixed Shelf Of Up To $50 Mln
Tuesday, 6 Mar 2018 

March 6 (Reuters) - Acasti Pharma Inc ::ACASTI PHARMA INC FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILING.  Full Article

Acasti Pharma Q3 ‍net Loss 2017 Was $0.40 Per Share​
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Acasti Pharma Inc ::ACASTI PHARMA REPORTS THIRD QUARTER FY 2018 FINANCIAL RESULTS.ACASTI PHARMA INC - ‍NET LOSS FOR QUARTER ENDED DECEMBER 31, 2017 WAS $0.40 PER SHARE​.  Full Article

Acasti Pharma grants Chinese pharma co exclusive license to commercialize CaPre in China​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc - ‍clarifies term of proposed strategic partnership with China pharmaceutical company​.Acasti - Under proposed term, Chinese pharmaceutical co to be granted exclusive license to commercialize CaPre in certain Asian countries including China​.  Full Article

Acasti Pharma ‍enters into non-binding agreement with China-based pharma
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc - ‍entered into a non-binding term sheet with a China-based pharmaceutical company​.Acasti Pharma - ‍if definitive agreement is reached, signed, term sheet contemplates co would receive an upfront payment of us$8 million upon signing.Acasti Pharma Inc - ‍if definitive agreement is reached & signed, co would also receive potential additional milestone payments in excess of $125 million​.  Full Article

Acasti Pharma says is offering 11.7 mln common shares‍​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Acasti Pharma Inc :Says it is offering 11.7 million common shares‍​ - SEC Filing.  Full Article

Acasti Pharma reports Q2 loss per share C‍$0.31​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Acasti Pharma Inc :Acasti Pharma reports second quarter FY 2018 financial results.Acasti Pharma Inc qtrly loss per share C‍$0.31​.  Full Article

Acasti Pharma files for offering of up to $17.25 mln of common stock‍​
Friday, 29 Sep 2017 

Sept 29 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc files for offering of up to $17.25 million of common stock‍​ - sec filing‍​.  Full Article

Acasti Pharma reports Q1 loss per share c$0.19
Monday, 14 Aug 2017 

Aug 14 (Reuters) - Acasti Pharma Inc -:Acasti Pharma reports first quarter fy 2018 financial results.Q1 loss per share c$0.19.  Full Article